Incidence, risk factors and treatment response in patients with chronic graft versus-host disease after haploidentical transplantation with post-transplantation cyclophosphamide

被引：0

作者：

Rivera, Daniel ^{[1
]}

Lopez-Corral, Lucia ^{[1
]}

Kwon, Mi ^{[2
]}

Bermudez, Arancha ^{[3
]}

Yanez, Lucrecia ^{[3
]}

Gallardo, Anabel ^{[4
]}

Cabrero, Monica ^{[1
]}

Champ, Diana ^{[2
]}

Garcia-Avila, Sara ^{[3
]}

Garcia, Abel ^{[4
]}

Perez, Estefania ^{[1
]}

Balsalobre, Pascual ^{[2
]}

Colorado, Mercedes ^{[3
]}

Jesus Pascual, Maria ^{[4
]}

Martin, Ana ^{[1
]}

Luis Diez, Jose ^{[2
]}

Gayoso, Jorge ^{[2
]}

Dolores Caballero, Maria ^{[1
]}

机构：

[1] Hosp Univ Salamanca IBSAL, Hematol, Salamanca, Spain

[2] Hosp 12 Octubre, Hematol, Madrid, Spain

[3] Hosp Marques Valdecilla, Hematol, Santander, Spain

[4] Hosp Carlos Haya, Hematol, Malaga, Spain

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P374

引用

页码：426 / 427

页数：2

共 50 条

[1] Incidence, Risk Factors and Treatment Response in Patients with Chronic Graft versus-Host Disease after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
Rivera, Daniel
Lopez Corral, Lucia
Kwon, Mi
Yanez, Lucrecia
Pascual Cascon, Maria Jesus
Cabrero, Monica
Champ, Diana
Garcia-Avila, Sara
Gallardo Morillo, Anabel
Perez, Estefania
Balsalobre, Pascual
Colorado, Mercedes
Garcia Sola, Abel
Martin, Ana
Luis Diez, Jose
Bermudez, Arancha
Galloso, Jorge
Dolores Caballero, Maria
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S304 - S304
[2] INCIDENCE, RISK FACTORS AND RESPONSE TO THE TREATMENT OF GRAFTED DISEASE AGAINST CHRONIC RECEPTOR AFTER HAPLOIDENTICAL TRANSPLANTATION WITH CYCLOPHOSPHAMIDE POST-TRANSPLANT
Rivera, D.
Lopez Corral, L.
Champ, D.
Yanez, L.
Cabrero, M.
Kwon, M.
Garcia Avila, S.
Perez, E.
Balsalobre, P.
Colorado, M.
Martin, A. A.
Diez, J. L.
Bermudez, A.
Gayoso, J.
Caballero, M. D.
[J]. HAEMATOLOGICA, 2017, 102 : 210 - 211
[3] Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis
Jain, Tania
Tsai, Hua-Ling
DeZern, Amy E.
Gondek, Lukasz P.
Elmariah, Hany
Bolanos-Meade, Javier
Luznik, Leonido
Fuchs, Ephraim
Ambinder, Richard
Gladstone, Douglas E.
Imus, Philip
Webster, Jonathan
Prince, Gabrielle
Ghiaur, Gabriel
Smith, B. Douglas
Ali, Syed Abbas
Ambinder, Alexander
Dalton, William B.
Gocke, Christian B.
Huff, Carol Ann
Gojo, Ivana
Swinnen, Lode
Wagner-Johnston, Nina
Borrello, Ivan
Varadhan, Ravi
Levis, Mark
Jones, Richard J.
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 259.e1 - 259.e11
[4] Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide As Graft Versus-Host Disease Prophylaxis in Pediatric Hematologic Malignancies
Lopez-Hernandez, Gerardo
Lopez-Santiago, Norma
Olaya-Vargas, Alberto
Perez-Garcia, Martin
Nideshda Ramirez-Uribe, Rosa Maria
del Pilar Salazar-Rosales, Haydee
Del Campo-Martinez, Angeles
Alejandra Xiqui-Jardines, Laura
[J]. BLOOD, 2018, 132
[5] Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis
Castagna, Luca
Mussetti, Alberto
Devillier, Raynier
Dominietto, Alida
Marcatti, Magda
Milone, Giuseppe
Maura, Francesco
de Philippis, Chiara
Bruno, Benedetto
Furst, Sabine
Blaise, Didier
Corradini, Paolo
Montefusco, Vittorio
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1549 - 1554
[6] Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation
Konuma, Takaaki
Matsuda, Kensuke
Shimomura, Yoshimitsu
Tanoue, Susumu
Sugita, Junichi
Inamoto, Yoshihiro
Hirayama, Masahiro
Ara, Takahide
Nakamae, Hirohisa
Ota, Shuichi
Maruyama, Yumiko
Eto, Tetsuya
Uchida, Naoyuki
Tanaka, Masatsugu
Ishiwata, Kazuya
Koi, Satoshi
Takahashi, Satoshi
Ozawa, Yukiyasu
Onizuka, Makoto
Kanda, Yoshinobu
Kimura, Takafumi
Ichinohe, Tatsuo
Atsuta, Yoshiko
Kanda, Junya
Yanada, Masamitsu
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 365.e1 - 365.e11
[7] Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
Kanakry, Jennifer A.
Kasamon, Yvette L.
Bolanos-Meade, Javier
Borrello, Ivan M.
Brodsky, Robert A.
Fuchs, Ephraim J.
Ghosh, Nilanjan
Gladstone, Douglas E.
Gocke, Christopher D.
Huff, Carol Ann
Kanakry, Christopher G.
Luznik, Leo
Matsui, William
Mogri, Huzefa J.
Swinnen, Lode J.
Symons, Heather J.
Jones, Richard J.
Anibinder, Richard E.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (10) : 1514 - 1517
[8] Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
Jullien, Maxime
Orvain, Corentin
Berceanu, Ana
Couturier, Marie-Anne
Guillaume, Thierry
Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Klemencie, Marion
Schmidt, Aline
Hunault, Mathilde
Daguindau, Etienne
Roussel, Xavier
Delepine, Pascal
Guillerm, Gaelle
Giltat, Aurelien
Francois, Sylvie
Thepot, Sylvain
Le Gouill, Steven
Bene, Marie-C
Chevallier, Patrice
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 861.e1 - 861.e7
[9] Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
Elmariah, Hany
Otoukesh, Salman
Kumar, Ambuj
Ali, Haris
Arslan, Shukaib
Shouse, Geoffrey
Pourhassan, Hoda
Nishihori, Taiga
Faramand, Rawan
Mishra, Asmita
Khimani, Farhad
Fernandez, Hugo
Lazaryan, Aleksandr
Nieder, Michael
Perez, Lia
Liu, Hien
Nakamura, Ryotaro
Pidala, Joseph
Marcucci, Guido
Forman, Stephen J.
Anasetti, Claudio
Locke, Frederick
Bejanyan, Nelli
Malki, Monzr M. Al
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : e1 - e11
[10] Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
Im, Annie
Rashidi, Armin
Wang, Tao
Hemmer, Michael
MacMillan, Margaret L.
Pidala, Joseph
Jagasia, Madan
Pavletic, Steven
Majhail, Navneet S.
Weisdorf, Daniel
Abdel-Azim, Hisham
Agrawal, Vaibhav
Al-Homsi, A. Samer
Aljurf, Mahmoud
Askar, Medhat
Auletta, Jeffery J.
Bashey, Asad
Beitinjaneh, Amer
Bhatt, Vijaya Raj
Byrne, Michael
Cahn, Jean-Yves
Cairo, Mitchell
Castillo, Paul
Cerny, Jan
Chhabra, Saurabh
Choe, Hannah
Ciurea, Stefan
Daly, Andrew
Diaz Perez, Miguel Angel
Farhadfar, Nosha
Gadalla, Shahinaz M.
Gale, Robert
Ganguly, Siddhartha
Gergis, Usama
Hanna, Rabi
Hematti, Peiman
Herzig, Roger
Hildebrandt, Gerhard C.
Lad, Deepesh P.
Lee, Catherine
Lehmann, Leslie
Lekakis, Lazaros
Kamble, Rammurti T.
Kharfan-Dabaja, Mohamed A.
Khandelwal, Pooja
Martino, Rodrigo
Murthy, Hemant S.
Nishihori, Taiga
O'Brien, Tracey A.
Olsson, Richard F.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1459 - 1468

← 1 2 3 4 5 →